/5
0 avis
DESCRIPTION IN REAL-WORLD OF THE EFFICACY AFTER SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS ADMINISTRATION OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS. THE ROSWITCH STUDY
Archive ouverte
Edité par CCSD ; BMJ Publishing Group -
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, NETHERLANDS, JUN 13-16, 2018. International audience
Consulter en ligne
Chargement des enrichissements...